Fate Therapeutics Price Chart
Fate Therapeutics Volume Chart
Fate Therapeutics Market Segments
After Hours
-0.00(-0.03%)
| Open | $2.58 |
|---|---|
| Close | $2.58 |
| Low | $2.58 |
| Low Change | -0.00 (-0.03%) |
| High | $2.58 |
| High Change | +0.00 (+0.02%) |
| Range | $0.00 |
| Volume | 1.187K |
| Dollar Volume | $3.06K |
Regular Trading Hours
-0.15(-5.35%)
| Open | $2.71 |
|---|---|
| Close | $2.57 |
| Low | $2.55 |
| Low Change | -0.16 (-5.91%) |
| High | $2.77 |
| High Change | +0.06 (+2.26%) |
| Range | $0.22 |
| Volume | 2.828M |
| Dollar Volume | $7.25M |
Premarket
+0.10(+3.75%)
| Open | $2.67 |
|---|---|
| Close | $2.77 |
| Low | $2.67 |
| Low Change | 0.00 (0.00%) |
| High | $2.77 |
| High Change | +0.10 (+3.75%) |
| Range | $0.10 |
| Volume | 10.373K |
| Dollar Volume | $28.73K |
After Hours Yesterday
-0.00(-0.03%)
| Open | $2.58 |
|---|---|
| Close | $2.58 |
| Low | $2.58 |
| Low Change | -0.00 (-0.03%) |
| High | $2.58 |
| High Change | +0.00 (+0.02%) |
| Range | $0.00 |
| Volume | 1.187K |
| Dollar Volume | $3.06K |
Regular Trading Hours Yesterday
-0.15(-5.35%)
| Open | $2.71 |
|---|---|
| Close | $2.57 |
| Low | $2.55 |
| Low Change | -0.16 (-5.91%) |
| High | $2.77 |
| High Change | +0.06 (+2.26%) |
| Range | $0.22 |
| Volume | 2.828M |
| Dollar Volume | $7.25M |
Premarket Yesterday
+0.10(+3.75%)
| Open | $2.67 |
|---|---|
| Close | $2.77 |
| Low | $2.67 |
| Low Change | 0.00 (0.00%) |
| High | $2.77 |
| High Change | +0.10 (+3.75%) |
| Range | $0.10 |
| Volume | 10.373K |
| Dollar Volume | $28.73K |
Fate Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.54 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.25 |
| 20 Day Moving Average (SMA20) | $2.20 |
| 50 Day Moving Average (SMA50) | $1.64 |
| 100 Day Moving Average (SMA100) | $1.44 |
| 200 Day Moving Average (SMA200) | $1.29 |
Fate Therapeutics Statistics
| Average Volume (30 Days) | 3.74M |
|---|---|
| P/E Ratio (Current) | -2.56 |
| EPS (Current) | -$1.11 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$108.09M |
| Cash Ratio | 1.29 |
| Current Ratio | 5.85 |
| Quick Ratio | 5.85 |
| Debt to Equity | 0.00 |
| Enterprise Value | $291.46M |
| EV to EBITDA | -2.30 |
| EV to Sales | 46.15 |
| Price to Book | 1.84 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 52.41 |
| Return on Assets | -0.46% |
| Return on Equity | -0.72% |
Fate Therapeutics Stock Splits
There have been no stock splits for Fate Therapeutics (FATE).
Fate Therapeutics Dividends
There have been no dividends for Fate Therapeutics (FATE).